Answers are grounded in this paper and cite their sources.
Findings show that cardiometabolic risk factors affect morbidity in alcohol-associated liver disease, suggesting improved management strategies may be needed.
Among individuals with ALD, CMRF does not increase short- to intermediate-term mortality but identifies a phenotype with substantially higher liver, cardiovascular and infectious morbidity. Systematic detection and intensive management of CMRF should be integrated into ALD care pathways.
No takes yet. Share an insight, caveat, or question.
Danpanichkul et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: